Secukinumab

Secukinumab is a biologic medication used to treat autoimmune conditions such as plaque psoriasis, psoriatic arthritis, and ankylosing spondylitis. It works by targeting and inhibiting interleukin-17A (IL-17A), a protein involved in inflammation and immune responses. By blocking IL-17A, Secukinumab reduces inflammation and helps control symptoms associated with these chronic conditions.

Uses of Secukinumab

• Treatment of moderate to severe plaque psoriasis
• Management of psoriatic arthritis
• Treatment of ankylosing spondylitis

How Secukinumab Works

Secukinumab binds to and inhibits interleukin-17A (IL-17A), a cytokine that plays a key role in causing inflammation, thus reducing symptoms and disease progression.

Benefits of Secukinumab

• Effectively reduces skin lesions and joint inflammation
• Improves quality of life in autoimmune disease patients
• Targets specific immune pathways for precise treatment

How to Take Secukinumab

Secukinumab is administered by subcutaneous injection, typically once a week for the first month, then monthly thereafter. Follow your healthcare provider's instructions carefully.

Type of Dosage Available

• Pre-filled syringe for subcutaneous injection

Side Effects of Secukinumab

• Upper respiratory infections
• Headache
• Fatigue
• Injection site reactions
• Possible increased risk of infections

Safety Advice

• Inform your doctor if you have infections or immune system problems
• Avoid live vaccines during treatment
• Report any signs of infection immediately
• Do not stop treatment without consulting your doctor

Frequently Asked Questions (FAQs)

Q. What conditions does Secukinumab treat?
A. It is used for plaque psoriasis, psoriatic arthritis, and ankylosing spondylitis.


Q. How is Secukinumab administered?
A. By subcutaneous injection, following the prescribed schedule.


Q. Can Secukinumab increase infection risk?
A. Yes, it may increase the risk of infections, so report symptoms early.


Q. Are there side effects at the injection site?
A. Yes, mild reactions like redness or pain may occur.


Q. Should I avoid vaccines during treatment?
A. Avoid live vaccines while on Secukinumab.